Subscribe Sign In

Why register?

Home
News
Events
- Find an event
- Live event coverage
Deep Dive
Sales and marketing
Digital
Market Access
Oncology
Patients
R&D
Spotlight On
- Frontiers Health 2021
- The Future of Generics
Advertise

Search

Search

Close

Trending

Bayer grabs Chinese okay for CKD therapy Kerendia

Novartis eyes earlier use of PD-1 drug in oesophageal cancer

A 3-step guide to addressing difficult issues and creating mutual solutions

AZ takes aim at BMS’ lead in neoadjuvant NSCLC

Blueprint cashes in on the past to build its future

Retevmo

Roche_labcoat

News/ News/ Oncology

Roche, Blueprint’s RET cancer drug Gavreto cleared in EU

Phil Taylor Blueprint Medicines, Eli Lilly, EU, Gavreto, Oncology, regulatory approval, RET inhibitor, Retevmo, Roche 0 Comment

Roche and Blueprint Medicines have opened a second front in their rivalry with Eli Lilly in RET-mutated cancers,

X

Roche, Blueprint’s RET cancer drug Gavreto cleared in EU

https://pharmaphorum.com/news/roche-blueprints-ret-cancer-drug-gavreto-cleared-in-eu/

blueprint_logo

News/ News/ Oncology

Roche, Blueprint raise pressure on Lilly with new Gavreto approval

Phil Taylor Blueprint Medicines, Gavreto, imaging, Oncology, Retevmo, Roche, thyroid cancer 0 Comment

The FDA has cleared Roche and Blueprint Medicine’s Gavreto for a new use in RET-mutated thyroid cancer, putting

X

Roche, Blueprint raise pressure on Lilly with new Gavreto approval

https://pharmaphorum.com/news/roche-blueprint-raise-pressure-on-lilly-with-new-gavreto-approval/

Get in-depth news, opinions and features on pharma and healthcare sent straight to your inbox

Featured content

How to improve payer engagement with tailored value communication

How to improve payer engagement with tailored value communication

How will NICE fare in a post-Brexit world?

How will NICE fare in a post-Brexit world?

Events

MAPS 2018 EMEA Annual Meeting

MAPS 2018 EMEA Annual Meeting

Cell & Gene Therapy 2018

Cell & Gene Therapy 2018

Patient Engagement Event - a real world snapshot, beyond the talk

Patient Engagement Event - a real world snapshot, beyond the talk

Most popular

Most Viewed

Pfizer seeks to overturn three RSV vaccine patents held by GSK
Novartis will shed 7% of workforce in restructuring, say reports
Gilead tries again with twice-yearly HIV drug lenacapavir
Pfizer and Roivant launch autoimmune specialist Priovant
Merck launches accelerator programme for AI startups

Tweets from @pharmaphorum

Tweets by @pharmaphorum

Advertise
pharmaphorum connect

Contribute
Work for pharmaphorum

About us
Contact us
Privacy policy
Terms & conditions
Cookie Policy

The rights of trade mark owners are acknowledged. pharmaphorum media limited

Website and content copyright © 2009-, pharmaphorum media limited or its licensors; all rights reserved.

© 2022

Powered by WordPress • Themify WordPress Themes

Login

Username or Email Address

Password

Remember Me

Lost your password?

CONTINUE TO SITE >

Close in 10 seconds

Pharmaphorum.com